— Know what they know.
Not Investment Advice
Also trades as: 2142.HK (HKSE) · $vol 12M

HBMHF OTC

HBM Holdings Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -38.1% 1Y: -8.8%
$1.56
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 42 · $1.3B mcap · 562M float · 0.0000% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$215M -5.9% ▼
5Y CAGR: +25.3%
Total Liabilities
$91M -16.4% ▼
5Y CAGR: -16.4%
Shareholders Equity
$124M +3.7% ▲
Cash & Investments
$167M +18.5% ▲
5Y CAGR: +37.6%
Total Debt
$61M -7.1% ▼
5Y CAGR: -21.4%
Net Debt
-$105M -41.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$257M$56M$162M$140M$167M
Short-Term Investments$100M$160M$10M$401K$0
Cash & ST Investments$357M$216M$172M$141M$167M
Net Receivables$6M$26K$28M$65M$21M
Inventory$0$0$1M$0$2M
Other Current Assets$0$25M$29M$4M$2M
Total Current Assets$369M$241M$209M$210M$196M
Property, Plant & Equip.$12M$19M$8M$5M$4M
Goodwill & Intangibles$8M$8M$8M$8M$8M
Long-Term Investments$0$14M$7M$6M$8M
Other Non-Current Assets$29K$0$629K$2K$25K
Total Non-Current Assets$19M$41M$23M$18M$19M
Total Assets$389M$282M$232M$228M$215M
— Liabilities —
Accounts Payable$8M$26M$22M$15M$5M
Short-Term Debt-$1M$797K$41M$37M$56M
Deferred Revenue$0$1M$1M$17K$0
Other Current Liabilities$12M-$6M$5M$4M$7M
Total Current Liabilities$26M$41M$75M$64M$69M
Long-Term Debt$0$11M$47M$28M$4M
Other Non-Current Liab.$0$0$0$4K$0
Total Non-Current Liabilities$2M$18M$65M$45M$22M
Total Liabilities$28M$59M$139M$109M$91M
— Equity —
Common Stock$19K$19K$19K$19K$19K
Retained Earnings-$459M-$597M-$733M-$711M-$709M
Accumulated OCI$2M$6M$9M$14M$15M
Total Stockholders Equity$361M$223M$93M$120M$124M
Total Liabilities & Equity$389M$282M$232M$228M$215M
— Key Metrics —
Total Debt$2M$19M$91M$66M$61M
Net Debt-$255M-$37M-$71M-$74M-$105M
Total Investments$100M$174M$17M$6M$8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms